Related Experiment Video

Updated: Jan 30, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.4K

Histopathological Aspects of the Myocardium in Dilated Cardiomyopathy

R Mitrut1, A E Stepan2, D Pirici3

  • 1PhD student, Department of Pathology, University of Medicine and Pharmacy of Craiova.

Current Health Sciences Journal
|January 17, 2019
PubMed

Insights

Dilated cardiomyopathy, a common cardiac muscle disease, shows varied myocardial changes including cell size variations and fibrosis. These histopathological findings are nonspecific and seen in advanced heart conditions.

Area of Science:

  • Cardiology
  • Pathology
  • Histopathology

Background:

  • Dilated cardiomyopathy is the most prevalent cardiac muscle disease, representing 60% of all cardiomyopathies.
  • Understanding its histopathological features is crucial for diagnosis and management.

Purpose of the Study:

  • To identify and characterize the histopathological changes in the myocardium of patients with dilated cardiomyopathy.

Main Methods:

  • Analysis of myocardial tissue fragments from 19 deceased patients diagnosed with dilated cardiomyopathy.
  • Detailed histopathological examination of myocytes and interstitial components.

Main Results:

  • Observed a mix of hypertrophic, atrophic, and normal myocytes, often with hydropic changes.
  • Rarely found myocytosis, lipofuscin pigment, mucinous material, and nuclear pleomorphism.
  • Interstitial changes included fibrosis, lipomatosis, and occasional inflammatory infiltrate.

Conclusions:

  • Histopathological characteristics of dilated cardiomyopathy are diverse but not unique.
  • These findings are often nonspecific and can resemble changes seen in terminal stages of other cardiac diseases.

Keywords:
Dilated myocardiopathyhistopathology

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.0K
Technical Aspects of the Mouse Aortocaval Fistula06:12

Technical Aspects of the Mouse Aortocaval Fistula

Published on: July 11, 2013

17.5K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
563
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
486
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
532
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
442
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
603
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
354